Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1414 | 2675 | 22.3 | 49% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
1414 | 1 | CHEMOTHERAPY-TOKYO//JAPANESE JOURNAL OF ANTIBIOTICS//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2675 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | journal | 472550 | 3% | 47% | 88 |
2 | JAPANESE JOURNAL OF ANTIBIOTICS | journal | 330137 | 2% | 64% | 45 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | journal | 99028 | 12% | 3% | 329 |
4 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | journal | 53461 | 12% | 1% | 333 |
5 | CHEMOTHERAPY | journal | 47662 | 4% | 4% | 103 |
6 | CEFTRIAXONE | authKW | 45442 | 2% | 8% | 53 |
7 | INFECTION | journal | 45161 | 5% | 3% | 122 |
8 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | journal | 27716 | 3% | 4% | 67 |
9 | REVIEWS OF INFECTIOUS DISEASES | journal | 26577 | 3% | 3% | 77 |
10 | PHARMACOLOGY & PHARMACY | WoSSC | 24065 | 55% | 0% | 1471 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 24065 | 55% | 0% | 1471 |
2 | Infectious Diseases | 18120 | 25% | 0% | 664 |
3 | Microbiology | 16401 | 33% | 0% | 886 |
4 | Medicine, General & Internal | 1466 | 12% | 0% | 327 |
5 | Pediatrics | 397 | 5% | 0% | 139 |
6 | Oncology | 354 | 8% | 0% | 216 |
7 | Pathology | 310 | 4% | 0% | 100 |
8 | Immunology | 186 | 6% | 0% | 158 |
9 | Toxicology | 97 | 3% | 0% | 70 |
10 | Veterinary Sciences | 77 | 3% | 0% | 81 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RANCHI VET SCI ANIM HUSB | 15216 | 0% | 67% | 2 |
2 | CATEDRA INTRODUCC ZOOTEC | 11413 | 0% | 100% | 1 |
3 | CHILDRENS MEM HOSP PEDIAT INFECT DIS | 11413 | 0% | 100% | 1 |
4 | CHILDRENS MEM HOSP PHARMACEUT | 11413 | 0% | 100% | 1 |
5 | CHU TIMONE MARSEILLE | 11413 | 0% | 100% | 1 |
6 | CIENCIAS SALUD CIENCIAS PRECLIN | 11413 | 0% | 100% | 1 |
7 | CLIN PHARMACOL BIOSTAT RD | 11413 | 0% | 100% | 1 |
8 | DIRECC TOXICOL LEGAL MED | 11413 | 0% | 100% | 1 |
9 | DRUG 2 RD | 11413 | 0% | 100% | 1 |
10 | ETUDES PERINAT OCEAN INDIEN EA7388 | 11413 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | 472550 | 3% | 47% | 88 |
2 | JAPANESE JOURNAL OF ANTIBIOTICS | 330137 | 2% | 64% | 45 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 99028 | 12% | 3% | 329 |
4 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 53461 | 12% | 1% | 333 |
5 | CHEMOTHERAPY | 47662 | 4% | 4% | 103 |
6 | INFECTION | 45161 | 5% | 3% | 122 |
7 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 27716 | 3% | 4% | 67 |
8 | REVIEWS OF INFECTIOUS DISEASES | 26577 | 3% | 3% | 77 |
9 | PATHOLOGIE BIOLOGIE | 23625 | 4% | 2% | 95 |
10 | CHEMIOTERAPIA | 8154 | 1% | 4% | 16 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BALANT, L , DAYER, P , AUCKENTHALER, R , (1985) CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS.CLINICAL PHARMACOKINETICS. VOL. 10. ISSUE 2. P. 101-143 | 183 | 81% | 94 |
2 | CARMINE, AA , BROGDEN, RN , HEEL, RC , ROMANKIEWICZ, JA , SPEIGHT, TM , AVERY, GS , (1983) MOXALACTAM (LATAMOXEF) - A REVIEW OF ITS ANTI-BACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 26. ISSUE 4. P. 279-333 | 198 | 77% | 12 |
3 | CHERUBIN, CE , ENG, RHK , NORRBY, R , MODAI, J , HUMBERT, G , OVERTURF, G , (1989) PENETRATION OF NEWER CEPHALOSPORINS INTO CEREBROSPINAL-FLUID.REVIEWS OF INFECTIOUS DISEASES. VOL. 11. ISSUE 4. P. 526-548 | 100 | 91% | 57 |
4 | CARMINE, AA , BROGDEN, RN , HEEL, RC , SPEIGHT, TM , AVERY, GS , (1983) CEFOTAXIME - A REVIEW OF ITS ANTI-BACTERIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 25. ISSUE 3. P. 223-289 | 177 | 70% | 67 |
5 | RICHARDS, DM , BROGDEN, RN , (1985) CEFTAZIDIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 29. ISSUE 2. P. 105-161 | 138 | 67% | 79 |
6 | BEAM, TR , POLK, R , BARRIERE, SL , (1985) CEFTRIAXONE - A BETA-LACTAMASE STABLE, BROAD-SPECTRUM CEPHALOSPORIN WITH AN EXTENDED HALF-LIFE.PHARMACOTHERAPY. VOL. 5. ISSUE 5. P. 237-253 | 111 | 77% | 21 |
7 | RICHARDS, DM , HEEL, RC , BROGDEN, RN , SPEIGHT, TM , AVERY, GS , (1984) CEFTRIAXONE - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 27. ISSUE 6. P. 469-527 | 107 | 70% | 126 |
8 | BROGDEN, RN , WARD, A , (1988) CEFTRIAXONE - A REAPPRAISAL OF ITS ANTIBACTERIAL ACTIVITY AND PHARMACOKINETIC PROPERTIES, AND AN UPDATE ON ITS THERAPEUTIC USE WITH PARTICULAR REFERENCE TO ONCE-DAILY ADMINISTRATION.DRUGS. VOL. 35. ISSUE 6. P. 604-645 | 101 | 64% | 63 |
9 | NEU, HC , (1987) CEPHALOSPORINS IN THE TREATMENT OF MENINGITIS.DRUGS. VOL. 34. ISSUE . P. 135-153 | 75 | 90% | 48 |
10 | TODD, PA , BROGDEN, RN , (1990) CEFOTAXIME - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE.DRUGS. VOL. 40. ISSUE 4. P. 608-651 | 115 | 45% | 27 |
Classes with closest relation at Level 1 |